Ionising radiation

Malignant neoplasm of the gallbladder - Ionising radiation Factor

Last reviewed for CCPS 18 July 2007.

Investigative Documents

Claimant Report - Exposure to Ionising Radiation from Alpha Particles [CR9264]

Preliminary questions [37947]

36217

there is some evidence that ionising radiation may be a factor in the development of the condition under consideration.

36218 the veteran has received ionising radiation from internal deposition of a substance which emits alpha particles at some time.

37948

the veteran has received ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles at some time.

37950 — the veteran has established the causal connection between ionising radiation and VEA service for the clinical onset of malignant neoplasm of the gallbladder.

37951 — the veteran has established the causal connection between ionising radiation and operational service for the clinical onset of malignant neoplasm of the gallbladder.

or

37952 — the veteran has established the causal connection between ionising radiation and eligible service for the clinical onset of malignant neoplasm of the gallbladder.

Clinical onset and operational service [37951]

37953

on operational service, the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles.

37955

on operational service, the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles at least two years before the clinical onset of the condition under consideration.

37965

the veteran receiving a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles at least two years before the clinical onset of the condition under consideration, on operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

37958

the veteran received ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles due to an illness or injury which is identifiable.

37959 as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles.

37961

as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles at least two years before the clinical onset of the condition under consideration.

37963 — the identified illness or injury, as a consequence of which the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles, is causally related to operational service.

Clinical onset and eligible service [37952]

37954

on eligible service, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles.

37956

as a causal result of eligible service, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles.

37957

as a causal result of eligible service, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles at least two years before the clinical onset of the condition under consideration.

37966

the veteran receiving a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles at least two years before the clinical onset of the condition under consideration, on eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

37958

the veteran received ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles due to an illness or injury which is identifiable.

37960 as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles.

37962

as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles at least two years before the clinical onset of the condition under consideration.

37964 — the identified illness or injury, as a consequence of which the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by malignant neoplasm of the gallbladder from internal deposition of a substance which emits alpha particles, is causally related to eligible service.